Literature DB >> 29397066

Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy.

Zehuan Liao1, Zhen Wei Tan2, Pengcheng Zhu1, Nguan Soon Tan3.   

Abstract

There is much cellular heterogeneity in the tumor microenvironment. The tumor epithelia and stromal cells co-evolve, and this reciprocal relationship dictates almost every step of cancer development and progression. Despite this, many anticancer therapies are designed around druggable features of tumor epithelia, ignoring the supportive role of stromal cells. Cancer-associated fibroblasts (CAFs) are the dominant cell type within the reactive stroma of many tumor types. Numerous previous studies have highlighted a pro-tumorigenic role for CAFs via secretion of various growth factors, cytokines, chemokines, and the degradation of extracellular matrix. Recent works showed that CAFs secrete H2O2 to effect stromal-mediated field cancerization, transform primary epithelial cells, and aggravate cancer cell aggressiveness, in addition to inflammatory and mitogenic factors. Molecular characterization of CAFs also underscores the importance of Notch and specific nuclear receptor signaling in the activation of CAFs. This review consolidates recent findings of CAFs and highlights areas for future investigations.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer-associated fibroblasts; Field cancerization; Metastasis; Somatic Mutation Theory; Tissue Organization Field Theory; Tumor microenvironment

Mesh:

Year:  2018        PMID: 29397066     DOI: 10.1016/j.cellimm.2017.12.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  79 in total

Review 1.  Lipid Metabolism in Tumor-Associated Fibroblasts.

Authors:  Hongzhong Li; Jingyuan Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma.

Authors:  Marina Domingo-Vidal; Diana Whitaker-Menezes; Cristina Martos-Rus; Patrick Tassone; Christopher M Snyder; Madalina Tuluc; Nancy Philp; Joseph Curry; Ubaldo Martinez-Outschoorn
Journal:  Mol Cancer Res       Date:  2019-06-25       Impact factor: 5.852

3.  Myofibroblast Markers and Microscopy Detection Methods in Cell Culture and Histology.

Authors:  Fereshteh S Younesi; Dong Ok Son; Joao Firmino; Boris Hinz
Journal:  Methods Mol Biol       Date:  2021

4.  Mammary fibroblasts remodel fibrillar collagen microstructure in a biomimetic nanocomposite hydrogel.

Authors:  Chun Liu; Benjamin Chiang; Daniela Lewin Mejia; Kathryn E Luker; Gary D Luker; Andre Lee
Journal:  Acta Biomater       Date:  2018-11-07       Impact factor: 8.947

5.  Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor-Dependent Serrated Polyps in Mouse Cecum.

Authors:  Zhengxiang He; Lili Chen; Grace Chen; Paola Smaldini; Gerold Bongers; Jovani Catalan-Dibene; Glaucia C Furtado; Sergio A Lira
Journal:  Gastroenterology       Date:  2019-08-27       Impact factor: 22.682

6.  α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC).

Authors:  Fengzhou Li; Shilei Zhao; Yanwei Cui; Tao Guo; Jiaqi Qiang; Qiang Xie; Wendan Yu; Wei Guo; Wuguo Deng; Chundong Gu; Taihua Wu
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

7.  IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.

Authors:  Manuel Röhrich; Anastasia Loktev; Annika K Wefers; Annette Altmann; Daniel Paech; Sebastian Adeberg; Paul Windisch; Thomas Hielscher; Paul Flechsig; Ralf Floca; Dominik Leitz; Julius P Schuster; Peter E Huber; Jürgen Debus; Andreas von Deimling; Thomas Lindner; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-06       Impact factor: 9.236

Review 8.  Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression.

Authors:  Andrew C Nelson; Heather L Machado; Kathryn L Schwertfeger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-08-31       Impact factor: 2.673

9.  Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice.

Authors:  Mark Wei Yi Tan; Ming Keat Sng; Hong Sheng Cheng; Zun Siong Low; Benjamin Jia Juin Leong; Damien Chua; Eddie Han Pin Tan; Jeremy Soon Kiat Chan; Yun Sheng Yip; Yin Hao Lee; Mintu Pal; Xiaomeng Wang; Walter Wahli; Nguan Soon Tan
Journal:  Cell Death Differ       Date:  2020-04-20       Impact factor: 15.828

Review 10.  Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.

Authors:  Wenpan Li; Nicholas Little; Jonghan Park; Cole Alexander Foster; Jiawei Chen; Jianqin Lu
Journal:  Mol Pharm       Date:  2021-07-14       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.